Balance Sheet Data
Catalyst Pharmaceuticals, Inc. (CPRX)
$14.05
-0.16 (-1.13%)
Year A/P | 2018 Actual | 2019 Actual | 2020 Actual | 2021 Actual | 2022 Actual | 2023 Projected | 2024 Projected | 2025 Projected | 2026 Projected | 2027 Projected |
| Total Cash | 53.48 | 94.52 | 140.28 | 191.27 | 298.39 | 249,669.69 | 13,012,801.74 | 678,228,129.70 | 35,349,297,181.99 | 1,842,407,822,013.21 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Cash (%) | ||||||||||
| Account Receivables | - | 10.54 | 5.99 | 6.62 | 10.44 | 695.01 | 36,223.86 | 1,887,990.24 | 98,402,182.41 | 5,128,728,575.28 |
| Account Receivables (%) | ||||||||||
| Inventories | 0.06 | 1.96 | 4.65 | 7.87 | 6.81 | 575.76 | 30,008.66 | 1,564,053.55 | 81,518,579.38 | 4,248,754,013.93 |
| Inventories (%) | ||||||||||
| Accounts Payable | 2.34 | 4.12 | 4.26 | 2.77 | 3.97 | 10,693 | 557,319.77 | 29,047,545.16 | 1,513,960,069.54 | 78,907,703,877.86 |
| Accounts Payable (%) | ||||||||||
| Capital Expenditure | -0.09 | -0.02 | -0.01 | -1.02 | -0.03 | -428.05 | -22,310.10 | -1,162,804.08 | -60,605,429.44 | -3,158,759,187.93 |
| Capital Expenditure (%) |
To support growth, companies need to keep investing in capital items – including property, plants and equipment.
To calculate this net investment,we take capital expenditure (found in the company’s statement of cash flows)
and subtract non-cash depreciation (found on the income statement).
Working capital refers to the cash a company needs for day-to-day operations.
The faster a company expands, the more cash it will need.
To calculate working capital, we take current assets and subtract current liabilities.
You can find both of these on a company’s balance sheet, which is published in its quarterly and annual financial statements.